Rubicon Organics Inc (ROMJ) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.050x

Based on the latest financial reports, Rubicon Organics Inc (ROMJ) has a cash flow conversion efficiency ratio of 0.050x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$2.09 Million ≈ $1.51 Million USD) by net assets (CA$41.64 Million ≈ $30.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Rubicon Organics Inc for the company's overall valuation and market capitalisation.

Rubicon Organics Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Rubicon Organics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Rubicon Organics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rubicon Organics Inc ranked by their cash flow conversion efficiency. Explore ROMJ cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
NexgenRX Inc. V:NXG	0.106x
Cubic Digital Technology Co Ltd SHE:300344	-0.061x
Chin Yang Chem KO:051630	-0.010x
Naos Emerging Opportunities Company Ltd AU:NCC	0.055x
Nara Mold & Die Co. Ltd KQ:051490	-0.010x
Sungwoo Electronics Co. Ltd KQ:081580	0.054x
Grand House Mulia Pt JK:HOMI	0.019x
Complete Solaria, Inc NASDAQ:SPWR	0.057x

Annual Cash Flow Conversion Efficiency for Rubicon Organics Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Rubicon Organics Inc from 2016 to 2025. View latest Rubicon Organics Inc stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$44.06 Million ≈ $31.87 Million	CA$-3.04 Million ≈ $-2.20 Million	-0.069x	-175.90%
2024-12-31	CA$37.40 Million ≈ $27.06 Million	CA$3.40 Million ≈ $2.46 Million	0.091x	-49.29%
2023-12-31	CA$37.89 Million ≈ $27.41 Million	CA$6.79 Million ≈ $4.91 Million	0.179x	+251.92%
2022-12-31	CA$38.33 Million ≈ $27.73 Million	CA$1.95 Million ≈ $1.41 Million	0.051x	+118.97%
2021-12-31	CA$38.90 Million ≈ $28.14 Million	CA$-10.44 Million ≈ $-7.55 Million	-0.268x	+45.90%
2020-12-31	CA$28.84 Million ≈ $20.86 Million	CA$-14.31 Million ≈ $-10.35 Million	-0.496x	+9.39%
2019-12-31	CA$18.52 Million ≈ $13.39 Million	CA$-10.14 Million ≈ $-7.33 Million	-0.548x	-29.95%
2018-12-31	CA$22.06 Million ≈ $15.96 Million	CA$-9.30 Million ≈ $-6.73 Million	-0.421x	-67.63%
2017-12-31	CA$16.69 Million ≈ $12.07 Million	CA$-4.20 Million ≈ $-3.03 Million	-0.251x	-51097.63%
2016-12-31	CA$12.07 Million ≈ $8.73 Million	CA$5.95K ≈ $4.30K	0.000x	--

About Rubicon Organics Inc

V:ROMJ Canada Drug Manufacturers - Specialty & Generic

Market Cap

$23.47 Million

CA$32.44 Million CAD

Market Cap Rank

#24690 Global

#947 in Canada

Share Price

CA$0.48

Change (1 day)

+5.49%

52-Week Range

CA$0.42 - CA$0.66

All Time High

CA$4.31